Nektar Therapeutics Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include Stingray Therapeutics, Aura Biosciences, Signpath Pharma and Eleison Pharmaceuticals.
 Stingray Therapeutics Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer. |  Aura Biosciences ura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. |  Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. |  Eleison Pharmaceuticals Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers. | ||
Founding Date | Founding Date 1990 | Founding Date 2018 | Founding Date 2009 | Founding Date 2006 | Founding Date 2008 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Houston, US HQ | Locations Cambridge, US HQ | Locations Sandy, US HQ | Locations Princeton, US HQ |
Employees | Employees 61821% increase | Employees 7 | Employees 42 | Employees 11 | Employees 12 |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) N/A | Valuation ($) 544.2 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($119m) (FY, 2024) | Net income N/A | Net income ($86.9m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 45m | Total funding raised N/A | Total funding raised $ 213.9m | Total funding raised $ 5.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Stingray Therapeutics
HQ
Houston, US
Employees
7
Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer.
View companyAura Biosciences
HQ
Cambridge, US
Employees
42
ura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View companySignpath Pharma
HQ
Sandy, US
Employees
11
SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
View companyEleison Pharmaceuticals
HQ
Princeton, US
Employees
12
Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers.
View company